FDA releases final guidance document on guidelines for MIGS devices

The FDA has released a final guidance document for industry and FDA staff on devices to treat glaucoma.“Premarket studies of implantable minimally invasive glaucoma surgical (MIGS) devices” provides initial recommendations of nonclinical and clinical studies to support the development of premarket approval applications for MIGS devices, the document said.